Updated November 2024
Anti-Obesity Medications
We are not currently accepting referrals for anti-obesity medications until they have been approved onto the East Region prescription list. We can’t provide details on how long this will take at this time and unfortunately it is likely to be into 2025.
We apologise for the delay and thank you for your patience. These delays are unfortunately outwith our control and we are working hard to bring these medications to NHS Lothian.
We will update our website once we are able to accept referrals into our service for anti-obesity medications.
Please see further details below.
Wegovy® (semaglutide) & Mounjaro® (tirzepatide)
Wegovy® (semaglutide) & Mounjaro® (tirzepatide) have both been approved for use in NHS Scotland to support weight management for health reasons. However, these medications have yet to be added to the East Region prescription list; therefore we are unable to accept referrals for Wegovy® or Mounjaro at this time. We are working together with NHS Fife and NHS Borders to progress the addition of these medications to the East Region prescription list.
Once these medications are available you can find phase 1 criteria by clicking here.
Liraglutide (Saxenda®)
There continues to be an international supply issue with this medication.
Other Anti-Obesity Medications
Please note that there are no other anti-obesity medications approved for the purpose of weight management in NHS Scotland at present. Oral agents have only been licensed and approved for the management of Type 2 Diabetes. We will continue to update our website as new medications are approved and become available.
You can find more information about our other programmes and referral forms on our web page
Adult Weight Management and Type 2 Diabetes Prevention Service – NHS Lothian | Our Services
Adult Weight Management and Type 2 Diabetes Prevention Team
Woodlands House, Astley Ainslie Hospital, 74 Canaan Lane, Edinburgh, EH9 2TB
E-mail: loth.weightmanagement@nhs.scot
Telephone: 0131 537 9169
